RxDoctor Payments Data

Eugene Reilly, MD

Family Medicine · Cincinnati, OHNPI 1881695856

Payments from drug & device makers

$4,985in general payments, 2019–2025

Across 322 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$506
  • Lilly USA, LLC$429
  • Pfizer$369
  • Johnson & Johnson$308
  • Boehringer Ingelheim$300
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$4,980100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,985 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$126,179
Medicare patients
330
Services billed
1,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin88$124,444
EliquisApixaban134$113,351
MounjaroTirzepatide44$64,486
TrulicityDulaglutide33$62,783
OzempicSemaglutide55$58,190
XareltoRivaroxaban42$53,250
JanuviaSitagliptin Phosphate31$36,584
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$22,432
FarxigaDapagliflozin Propanediol26$22,411
Spiriva HandihalerTiotropium Bromide21$10,740
Bydureon BciseExenatide Microspheres12$9,750
Breo ElliptaFluticasone/Vilanterol21$9,228
Arnuity ElliptaFluticasone Furoate18$7,446
Repatha SureclickEvolocumab12$6,315
Atorvastatin Calcium870$5,322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$429$127,26977 claims
Boehringer IngelheimJardiance$300$124,44488 claims
PfizerEliquis, Paxlovid$369$116,210152 claims
Novo NordiskOzempic$506$58,19055 claims
Johnson & JohnsonXarelto$308$53,25042 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$263$39,10672 claims
MerckJanuvia$205$36,58431 claims
AstraZenecaFarxiga$255$22,41126 claims
AbbVieSynthroid$1,029$1,61341 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →